Cyclacel Pharma (CYCC) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	18.03M
Inventory
Prepaid expenses and other current assets
Total current assets	22.58M
Property, plant and equipment (net)	73K
Total assets	22.65M
Accounts payable	1.98M
Accrued liabilities and other current liabilities	3.56M
Warrant liability
Total current liabilities	5.57M
Total liabilities	5.71M
Preferred stock, $0.001 par value; 5,000,000 shares authorized at December 31, 2010 and June 30, 2011; 1,213,142 shares issued and outstanding at December 31, 2010 and June 30, 2011. Aggregate preference in liquidation (including undeclared cumulative dividends) of $13,344,562 at December 31, 2010 and June 30, 2011	0
Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2010 and June 30, 2011; 46,564,914 and 46,587,182 shares issued and outstanding at December 31, 2010 and June 30, 2011 respectively	4K
Additional paid-in capital	349.9M
Accumulated other comprehensive loss	-760K
Deficit accumulated during the development stage	-332.2M
Total stockholders' equity	16.94M
Total liabilities and stockholders' equity	22.65M

Entities mentioned with CYCC

View All Entities